Femto Technologies Secures $17 Million in Private Placement Funding for FemTech Innovation

Femto Technologies Inc., a FemTech pioneer, has successfully secured $17 million in a private placement financing round with institutional investors. The funding will support the company's ongoing research and development of its Sensera feminine wellness platform, which leverages proprietary Smart Release System (SRS) technology incorporating machine learning and artificial intelligence.

The private placement involves the sale of common shares and warrants at $4.17 per unit, with investors receiving both Series A and Series B warrants. Series A warrants have an exercise price of $5.21 and expire in 60 months, while Series B warrants have an exercise price of $12.51 and expire in 30 months.

The investment represents a significant milestone for Femto Technologies, which recently received a CES Innovation Awards® 2025 Honorary designation in the AI category for its Sensera device. The company intends to use the proceeds for general corporate purposes and working capital, potentially accelerating product development and market expansion.

Sensera aims to transform feminine wellness by providing a holistic self-care experience that adapts to women's changing needs. By integrating advanced technologies like machine learning and AI, the product seeks to bridge existing gaps in feminine health and personal wellness solutions.

The private placement signals growing investor confidence in FemTech innovations and highlights the increasing recognition of technology-driven approaches to women's health. Femto Technologies' strategic funding will likely support further research, product refinement, and potential market penetration for its innovative wellness platform.